LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 18

Search options

  1. Article ; Online: A Quantitative Genetic Interaction Map of HIV Infection.

    Gordon, David E / Watson, Ariane / Roguev, Assen / Zheng, Simin / Jang, Gwendolyn M / Kane, Joshua / Xu, Jiewei / Guo, Jeffrey Z / Stevenson, Erica / Swaney, Danielle L / Franks-Skiba, Kathy / Verschueren, Erik / Shales, Michael / Crosby, David C / Frankel, Alan D / Marson, Alexander / Marazzi, Ivan / Cagney, Gerard / Krogan, Nevan J

    Molecular cell

    2020  Volume 78, Issue 2, Page(s) 197–209.e7

    Abstract: We have developed a platform for quantitative genetic interaction mapping using viral infectivity as a functional readout and constructed a viral host-dependency epistasis map (vE-MAP) of 356 human genes linked to HIV function, comprising >63,000 ... ...

    Abstract We have developed a platform for quantitative genetic interaction mapping using viral infectivity as a functional readout and constructed a viral host-dependency epistasis map (vE-MAP) of 356 human genes linked to HIV function, comprising >63,000 pairwise genetic perturbations. The vE-MAP provides an expansive view of the genetic dependencies underlying HIV infection and can be used to identify drug targets and study viral mutations. We found that the RNA deadenylase complex, CNOT, is a central player in the vE-MAP and show that knockout of CNOT1, 10, and 11 suppressed HIV infection in primary T cells by upregulating innate immunity pathways. This phenotype was rescued by deletion of IRF7, a transcription factor regulating interferon-stimulated genes, revealing a previously unrecognized host signaling pathway involved in HIV infection. The vE-MAP represents a generic platform that can be used to study the global effects of how different pathogens hijack and rewire the host during infection.
    MeSH term(s) CD4-Positive T-Lymphocytes/immunology ; CD4-Positive T-Lymphocytes/pathology ; Epistasis, Genetic ; HIV Infections/genetics ; HIV Infections/immunology ; HIV Infections/pathology ; HIV Infections/virology ; HIV-1/genetics ; HIV-1/pathogenicity ; Host-Pathogen Interactions/genetics ; Host-Pathogen Interactions/immunology ; Humans ; Immunity, Innate/genetics ; Interferon Regulatory Factor-7/genetics ; Interferons/genetics ; Mutation ; Signal Transduction/genetics ; Transcription Factors/genetics
    Chemical Substances CNOT1 protein, human ; IRF7 protein, human ; Interferon Regulatory Factor-7 ; Transcription Factors ; Interferons (9008-11-1)
    Language English
    Publishing date 2020-02-20
    Publishing country United States
    Document type Journal Article ; Research Support, N.I.H., Extramural ; Research Support, Non-U.S. Gov't
    ZDB-ID 1415236-8
    ISSN 1097-4164 ; 1097-2765
    ISSN (online) 1097-4164
    ISSN 1097-2765
    DOI 10.1016/j.molcel.2020.02.004
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article: A SARS-CoV-2 protein interaction map reveals targets for drug repurposing

    Gordon, David E / Jang, Gwendolyn M / Bouhaddou, Mehdi / Xu, Jiewei / Obernier, Kirsten / White, Kris M / O039, / Meara, Matthew J / Rezelj, Veronica V / Guo, Jeffrey Z / Swaney, Danielle L / Tummino, Tia A / Huettenhain, Ruth / Kaake, Robyn M / Richards, Alicia L / Tutuncuoglu, Beril / Foussard, Helene / Batra, Jyoti / Haas, Kelsey /
    Modak, Maya / Kim, Minkyu / Haas, Paige / Polacco, Benjamin J / Braberg, Hannes / Fabius, Jacqueline M / Eckhardt, Manon / Soucheray, Margaret / Bennett, Melanie J / Cakir, Merve / McGregor, Michael J / Li, Qiongyu / Meyer, Bjoern / Roesch, Ferdinand / Vallet, Thomas / Mac Kain, Alice / Miorin, Lisa / Moreno, Elena / Naing, Zun Zar Chi / Zhou, Yuan / Peng, Shiming / Shi, Ying / Zhang, Ziyang / Shen, Wenqi / Kirby, Ilsa T / Melnyk, James E / Chorba, John S / Lou, Kevin / Dai, Shizhong A / Barrio-Hernandez, Inigo / Memon, Danish / Hernandez-Armenta, Claudia

    Nature (Lond.)

    Abstract: The novel coronavirus SARS-CoV-2, the causative agent of COVID-19 respiratory disease, has infected over 2.3 million people, killed over 160,000, and caused worldwide social and economic disruption1,2. There are currently no antiviral drugs with proven ... ...

    Abstract The novel coronavirus SARS-CoV-2, the causative agent of COVID-19 respiratory disease, has infected over 2.3 million people, killed over 160,000, and caused worldwide social and economic disruption1,2. There are currently no antiviral drugs with proven clinical efficacy, nor are there vaccines for its prevention, and these efforts are hampered by limited knowledge of the molecular details of SARS-CoV-2 infection. To address this, we cloned, tagged and expressed 26 of the 29 SARS-CoV-2 proteins in human cells and identified the human proteins physically associated with each using affinity-purification mass spectrometry (AP-MS), identifying 332 high-confidence SARS-CoV-2-human protein-protein interactions (PPIs). Among these, we identify 66 druggable human proteins or host factors targeted by 69 compounds (29 FDA-approved drugs, 12 drugs in clinical trials, and 28 preclinical compounds). Screening a subset of these in multiple viral assays identified two sets of pharmacological agents that displayed antiviral activity: inhibitors of mRNA translation and predicted regulators of the Sigma1 and Sigma2 receptors. Further studies of these host factor targeting agents, including their combination with drugs that directly target viral enzymes, could lead to a therapeutic regimen to treat COVID-19.
    Keywords covid19
    Publisher WHO
    Document type Article
    Note WHO #Covidence: #152254
    Database COVID19

    Kategorien

  3. Article: The Global Phosphorylation Landscape of SARS-CoV-2 Infection

    Bouhaddou, Mehdi / Memon, Danish / Meyer, Bjoern / White, Kris M / Rezelj, Veronica V / Correa Marrero, Miguel / Polacco, Benjamin J / Melnyk, James E / Ulferts, Svenja / Kaake, Robyn M / Batra, Jyoti / Richards, Alicia L / Stevenson, Erica / Gordon, David E / Rojc, Ajda / Obernier, Kirsten / Fabius, Jacqueline M / Soucheray, Margaret / Miorin, Lisa /
    Moreno, Elena / Koh, Cassandra / Tran, Quang Dinh / Hardy, Alexandra / Robinot, Rémy / Vallet, Thomas / Nilsson-Payant, Benjamin E / Hernandez-Armenta, Claudia / Dunham, Alistair / Weigang, Sebastian / Knerr, Julian / Modak, Maya / Quintero, Diego / Zhou, Yuan / Dugourd, Aurelien / Valdeolivas, Alberto / Patil, Trupti / Li, Qiongyu / Hüttenhain, Ruth / Cakir, Merve / Muralidharan, Monita / Kim, Minkyu / Jang, Gwendolyn / Tutuncuoglu, Beril / Hiatt, Joseph / Guo, Jeffrey Z / Xu, Jiewei / Bouhaddou, Sophia / Mathy, Christopher J P / Gaulton, Anna / Manners, Emma J

    Cell

    Abstract: The causative agent of the coronavirus disease 2019 (COVID-19) pandemic, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has infected millions and killed hundreds of thousands of people worldwide, highlighting an urgent need to develop ... ...

    Abstract The causative agent of the coronavirus disease 2019 (COVID-19) pandemic, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has infected millions and killed hundreds of thousands of people worldwide, highlighting an urgent need to develop antiviral therapies. Here we present a quantitative mass spectrometry-based phosphoproteomics survey of SARS-CoV-2 infection in Vero E6 cells, revealing dramatic rewiring of phosphorylation on host and viral proteins. SARS-CoV-2 infection promoted casein kinase II (CK2) and p38 MAPK activation, production of diverse cytokines, and shutdown of mitotic kinases, resulting in cell cycle arrest. Infection also stimulated a marked induction of CK2-containing filopodial protrusions possessing budding viral particles. Eighty-seven drugs and compounds were identified by mapping global phosphorylation profiles to dysregulated kinases and pathways. We found pharmacologic inhibition of the p38, CK2, CDK, AXL, and PIKFYVE kinases to possess antiviral efficacy, representing potential COVID-19 therapies.
    Keywords covid19
    Publisher WHO
    Document type Article
    Note WHO #Covidence: #624826
    Database COVID19

    Kategorien

  4. Article: Comparative host-coronavirus protein interaction networks reveal pan-viral disease mechanisms

    Gordon, David E / Hiatt, Joseph / Bouhaddou, Mehdi / Rezelj, Veronica V / Ulferts, Svenja / Braberg, Hannes / Jureka, Alexander S / Obernier, Kirsten / Guo, Jeffrey Z / Batra, Jyoti / Kaake, Robyn M / Weckstein, Andrew R / Owens, Tristan W / Gupta, Meghna / Pourmal, Sergei / Titus, Erron W / Cakir, Merve / Soucheray, Margaret / McGregor, Michael /
    Cakir, Zeynep / Jang, Gwendolyn / O039, / Meara, Matthew J / Tummino, Tia A / Zhang, Ziyang / Foussard, Helene / Rojc, Ajda / Zhou, Yuan / Kuchenov, Dmitry / Hüttenhain, Ruth / Xu, Jiewei / Eckhardt, Manon / Swaney, Danielle L / Fabius, Jacqueline M / Ummadi, Manisha / Tutuncuoglu, Beril / Rathore, Ujjwal / Modak, Maya / Haas, Paige / Haas, Kelsey M / Naing, Zun Zar Chi / Pulido, Ernst H / Shi, Ying / Barrio-Hernandez, Inigo / Memon, Danish / Petsalaki, Eirini / Dunham, Alistair / Marrero, Miguel Correa / Burke, David / Koh, Cassandra / Vallet, Thomas

    Science (Wash.)

    Abstract: The COVID-19 (Coronavirus disease-2019) pandemic, caused by the SARS-CoV-2 coronavirus, is a significant threat to public health and the global economy. SARS-CoV-2 is closely related to the more lethal but less transmissible coronaviruses SARS-CoV-1 and ... ...

    Abstract The COVID-19 (Coronavirus disease-2019) pandemic, caused by the SARS-CoV-2 coronavirus, is a significant threat to public health and the global economy. SARS-CoV-2 is closely related to the more lethal but less transmissible coronaviruses SARS-CoV-1 and MERS-CoV. Here, we have carried out comparative viral-human protein-protein interaction and viral protein localization analysis for all three viruses. Subsequent functional genetic screening identified host factors that functionally impinge on coronavirus proliferation, including Tom70, a mitochondrial chaperone protein that interacts with both SARS-CoV-1 and SARS-CoV-2 Orf9b, an interaction we structurally characterized using cryo-EM. Combining genetically-validated host factors with both COVID-19 patient genetic data and medical billing records identified important molecular mechanisms and potential drug treatments that merit further molecular and clinical study.
    Keywords covid19
    Publisher WHO
    Document type Article
    Note WHO #Covidence: #873450
    Database COVID19

    Kategorien

  5. Article: A SARS-CoV-2 protein interaction map reveals targets for drug repurposing

    Gordon, David E / Jang, Gwendolyn M / Bouhaddou, Mehdi / Xu, Jiewei / Obernier, Kirsten / White, Kris M / O039, / Meara, Matthew J / Rezelj, Veronica V / Guo, Jeffrey Z / Swaney, Danielle L / Tummino, Tia A / Hüttenhain, Ruth / Kaake, Robyn M / Richards, Alicia L / Tutuncuoglu, Beril / Foussard, Helene / Batra, Jyoti / Haas, Kelsey /
    Modak, Maya / Kim, Minkyu / Haas, Paige / Polacco, Benjamin J / Braberg, Hannes / Fabius, Jacqueline M / Eckhardt, Manon / Soucheray, Margaret / Bennett, Melanie J / Cakir, Merve / McGregor, Michael J / Li, Qiongyu / Meyer, Bjoern / Roesch, Ferdinand / Vallet, Thomas / Mac Kain, Alice / Miorin, Lisa / Moreno, Elena / Naing, Zun Zar Chi / Zhou, Yuan / Peng, Shiming / Shi, Ying / Zhang, Ziyang / Shen, Wenqi / Kirby, Ilsa T / Melnyk, James E / Chorba, John S / Lou, Kevin / Dai, Shizhong A / Barrio-Hernandez, Inigo / Memon, Danish / Hernandez-Armenta, Claudia

    Nature

    Abstract: A newly described coronavirus named severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which is the causative agent of coronavirus disease 2019 (COVID-19), has infected over 2.3 million people, led to the death of more than 160,000 individuals ...

    Abstract A newly described coronavirus named severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which is the causative agent of coronavirus disease 2019 (COVID-19), has infected over 2.3 million people, led to the death of more than 160,000 individuals and caused worldwide social and economic disruption1,2. There are no antiviral drugs with proven clinical efficacy for the treatment of COVID-19, nor are there any vaccines that prevent infection with SARS-CoV-2, and efforts to develop drugs and vaccines are hampered by the limited knowledge of the molecular details of how SARS-CoV-2 infects cells. Here we cloned, tagged and expressed 26 of the 29 SARS-CoV-2 proteins in human cells and identified the human proteins that physically associated with each of the SARS-CoV-2 proteins using affinity-purification mass spectrometry, identifying 332 high-confidence protein-protein interactions between SARS-CoV-2 and human proteins. Among these, we identify 66 druggable human proteins or host factors targeted by 69 compounds (of which, 29 drugs are approved by the US Food and Drug Administration, 12 are in clinical trials and 28 are preclinical compounds). We screened a subset of these in multiple viral assays and found two sets of pharmacological agents that displayed antiviral activity: inhibitors of mRNA translation and predicted regulators of the sigma-1 and sigma-2 receptors. Further studies of these host-factor-targeting agents, including their combination with drugs that directly target viral enzymes, could lead to a therapeutic regimen to treat COVID-19.
    Keywords covid19
    Publisher WHO
    Document type Article
    Note WHO #Covidence: #152254
    Database COVID19

    Kategorien

  6. Article: The Global Phosphorylation Landscape of SARS-CoV-2 Infection

    Bouhaddou, Mehdi / Memon, Danish / Meyer, Bjoern / White, Kris M / Rezelj, Veronica V / Correa Marrero, Miguel / Polacco, Benjamin J / Melnyk, James E / Ulferts, Svenja / Kaake, Robyn M / Batra, Jyoti / Richards, Alicia L / Stevenson, Erica / Gordon, David E / Rojc, Ajda / Obernier, Kirsten / Fabius, Jacqueline M / Soucheray, Margaret / Miorin, Lisa /
    Moreno, Elena / Koh, Cassandra / Tran, Quang Dinh / Hardy, Alexandra / Robinot, Rémy / Vallet, Thomas / Nilsson-Payant, Benjamin E / Hernandez-Armenta, Claudia / Dunham, Alistair / Weigang, Sebastian / Knerr, Julian / Modak, Maya / Quintero, Diego / Zhou, Yuan / Dugourd, Aurelien / Valdeolivas, Alberto / Patil, Trupti / Li, Qiongyu / Hüttenhain, Ruth / Cakir, Merve / Muralidharan, Monita / Kim, Minkyu / Jang, Gwendolyn / Tutuncuoglu, Beril / Hiatt, Joseph / Guo, Jeffrey Z / Xu, Jiewei / Bouhaddou, Sophia / Mathy, Christopher J.P / Gaulton, Anna / Manners, Emma J / Félix, Eloy / Shi, Ying / Goff, Marisa / Lim, Jean K / McBride, Timothy / O’Neal, Michael C / Cai, Yiming / Chang, Jason C.J / Broadhurst, David J / Klippsten, Saker / De wit, Emmie / Leach, Andrew R / Kortemme, Tanja / Shoichet, Brian / Ott, Melanie / Saez-Rodriguez, Julio / tenOever, Benjamin R / Mullins, R. Dyche / Fischer, Elizabeth R / Kochs, Georg / Grosse, Robert / García-Sastre, Adolfo / Vignuzzi, Marco / Johnson, Jeffery R / Shokat, Kevan M / Swaney, Danielle L / Beltrao, Pedro / Krogan, Nevan J

    Elsevier Inc. Cell. 2020 Aug. 06, v. 182, no. 3

    2020  

    Abstract: The causative agent of the coronavirus disease 2019 (COVID-19) pandemic, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has infected millions and killed hundreds of thousands of people worldwide, highlighting an urgent need to develop ... ...

    Abstract The causative agent of the coronavirus disease 2019 (COVID-19) pandemic, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has infected millions and killed hundreds of thousands of people worldwide, highlighting an urgent need to develop antiviral therapies. Here we present a quantitative mass spectrometry-based phosphoproteomics survey of SARS-CoV-2 infection in Vero E6 cells, revealing dramatic rewiring of phosphorylation on host and viral proteins. SARS-CoV-2 infection promoted casein kinase II (CK2) and p38 MAPK activation, production of diverse cytokines, and shutdown of mitotic kinases, resulting in cell cycle arrest. Infection also stimulated a marked induction of CK2-containing filopodial protrusions possessing budding viral particles. Eighty-seven drugs and compounds were identified by mapping global phosphorylation profiles to dysregulated kinases and pathways. We found pharmacologic inhibition of the p38, CK2, CDK, AXL, and PIKFYVE kinases to possess antiviral efficacy, representing potential COVID-19 therapies.
    Keywords COVID-19 infection ; Severe acute respiratory syndrome coronavirus 2 ; cell cycle checkpoints ; cytokines ; drugs ; etiological agents ; mass spectrometry ; mitogen-activated protein kinase ; mitosis ; non-specific serine/threonine protein kinase ; pandemic ; phosphorylation ; proteomics ; surveys ; viral proteins ; virion
    Language English
    Dates of publication 2020-0806
    Size p. 685-712.e19.
    Publishing place Elsevier Inc.
    Document type Article
    ZDB-ID 187009-9
    ISSN 1097-4172 ; 0092-8674
    ISSN (online) 1097-4172
    ISSN 0092-8674
    DOI 10.1016/j.cell.2020.06.034
    Database NAL-Catalogue (AGRICOLA)

    More links

    Kategorien

  7. Article: A SARS-CoV-2-Human Protein-Protein Interaction Map Reveals Drug Targets and Potential Drug-Repurposing.

    Gordon, David E / Jang, Gwendolyn M / Bouhaddou, Mehdi / Xu, Jiewei / Obernier, Kirsten / O'Meara, Matthew J / Guo, Jeffrey Z / Swaney, Danielle L / Tummino, Tia A / Hüttenhain, Ruth / Kaake, Robyn M / Richards, Alicia L / Tutuncuoglu, Beril / Foussard, Helene / Batra, Jyoti / Haas, Kelsey / Modak, Maya / Kim, Minkyu / Haas, Paige /
    Polacco, Benjamin J / Braberg, Hannes / Fabius, Jacqueline M / Eckhardt, Manon / Soucheray, Margaret / Bennett, Melanie J / Cakir, Merve / McGregor, Michael J / Li, Qiongyu / Naing, Zun Zar Chi / Zhou, Yuan / Peng, Shiming / Kirby, Ilsa T / Melnyk, James E / Chorba, John S / Lou, Kevin / Dai, Shizhong A / Shen, Wenqi / Shi, Ying / Zhang, Ziyang / Barrio-Hernandez, Inigo / Memon, Danish / Hernandez-Armenta, Claudia / Mathy, Christopher J P / Perica, Tina / Pilla, Kala B / Ganesan, Sai J / Saltzberg, Daniel J / Ramachandran, Rakesh / Liu, Xi / Rosenthal, Sara B / Calviello, Lorenzo / Venkataramanan, Srivats / Lin, Yizhu / Wankowicz, Stephanie A / Bohn, Markus / Trenker, Raphael / Young, Janet M / Cavero, Devin / Hiatt, Joe / Roth, Theo / Rathore, Ujjwal / Subramanian, Advait / Noack, Julia / Hubert, Mathieu / Roesch, Ferdinand / Vallet, Thomas / Meyer, Björn / White, Kris M / Miorin, Lisa / Agard, David / Emerman, Michael / Ruggero, Davide / García-Sastre, Adolfo / Jura, Natalia / von Zastrow, Mark / Taunton, Jack / Schwartz, Olivier / Vignuzzi, Marco / d'Enfert, Christophe / Mukherjee, Shaeri / Jacobson, Matt / Malik, Harmit S / Fujimori, Danica G / Ideker, Trey / Craik, Charles S / Floor, Stephen / Fraser, James S / Gross, John / Sali, Andrej / Kortemme, Tanja / Beltrao, Pedro / Shokat, Kevan / Shoichet, Brian K / Krogan, Nevan J

    bioRxiv : the preprint server for biology

    2020  

    Abstract: An outbreak of the novel coronavirus SARS-CoV-2, the causative agent of COVID-19 respiratory disease, has infected over 290,000 people since the end of 2019, killed over 12,000, and caused worldwide social and economic ... ...

    Abstract An outbreak of the novel coronavirus SARS-CoV-2, the causative agent of COVID-19 respiratory disease, has infected over 290,000 people since the end of 2019, killed over 12,000, and caused worldwide social and economic disruption
    Keywords covid19
    Language English
    Publishing date 2020-03-22
    Publishing country United States
    Document type Preprint
    DOI 10.1101/2020.03.22.002386
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article ; Online: The Global Phosphorylation Landscape of SARS-CoV-2 Infection.

    Bouhaddou, Mehdi / Memon, Danish / Meyer, Bjoern / White, Kris M / Rezelj, Veronica V / Correa Marrero, Miguel / Polacco, Benjamin J / Melnyk, James E / Ulferts, Svenja / Kaake, Robyn M / Batra, Jyoti / Richards, Alicia L / Stevenson, Erica / Gordon, David E / Rojc, Ajda / Obernier, Kirsten / Fabius, Jacqueline M / Soucheray, Margaret / Miorin, Lisa /
    Moreno, Elena / Koh, Cassandra / Tran, Quang Dinh / Hardy, Alexandra / Robinot, Rémy / Vallet, Thomas / Nilsson-Payant, Benjamin E / Hernandez-Armenta, Claudia / Dunham, Alistair / Weigang, Sebastian / Knerr, Julian / Modak, Maya / Quintero, Diego / Zhou, Yuan / Dugourd, Aurelien / Valdeolivas, Alberto / Patil, Trupti / Li, Qiongyu / Hüttenhain, Ruth / Cakir, Merve / Muralidharan, Monita / Kim, Minkyu / Jang, Gwendolyn / Tutuncuoglu, Beril / Hiatt, Joseph / Guo, Jeffrey Z / Xu, Jiewei / Bouhaddou, Sophia / Mathy, Christopher J P / Gaulton, Anna / Manners, Emma J / Félix, Eloy / Shi, Ying / Goff, Marisa / Lim, Jean K / McBride, Timothy / O'Neal, Michael C / Cai, Yiming / Chang, Jason C J / Broadhurst, David J / Klippsten, Saker / De Wit, Emmie / Leach, Andrew R / Kortemme, Tanja / Shoichet, Brian / Ott, Melanie / Saez-Rodriguez, Julio / tenOever, Benjamin R / Mullins, R Dyche / Fischer, Elizabeth R / Kochs, Georg / Grosse, Robert / García-Sastre, Adolfo / Vignuzzi, Marco / Johnson, Jeffery R / Shokat, Kevan M / Swaney, Danielle L / Beltrao, Pedro / Krogan, Nevan J

    Cell

    2020  Volume 182, Issue 3, Page(s) 685–712.e19

    Abstract: The causative agent of the coronavirus disease 2019 (COVID-19) pandemic, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has infected millions and killed hundreds of thousands of people worldwide, highlighting an urgent need to develop ... ...

    Abstract The causative agent of the coronavirus disease 2019 (COVID-19) pandemic, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has infected millions and killed hundreds of thousands of people worldwide, highlighting an urgent need to develop antiviral therapies. Here we present a quantitative mass spectrometry-based phosphoproteomics survey of SARS-CoV-2 infection in Vero E6 cells, revealing dramatic rewiring of phosphorylation on host and viral proteins. SARS-CoV-2 infection promoted casein kinase II (CK2) and p38 MAPK activation, production of diverse cytokines, and shutdown of mitotic kinases, resulting in cell cycle arrest. Infection also stimulated a marked induction of CK2-containing filopodial protrusions possessing budding viral particles. Eighty-seven drugs and compounds were identified by mapping global phosphorylation profiles to dysregulated kinases and pathways. We found pharmacologic inhibition of the p38, CK2, CDK, AXL, and PIKFYVE kinases to possess antiviral efficacy, representing potential COVID-19 therapies.
    MeSH term(s) A549 Cells ; Angiotensin-Converting Enzyme 2 ; Animals ; Antiviral Agents/pharmacology ; Betacoronavirus/metabolism ; COVID-19 ; Caco-2 Cells ; Casein Kinase II/antagonists & inhibitors ; Casein Kinase II/metabolism ; Chlorocebus aethiops ; Coronavirus Infections/metabolism ; Coronavirus Infections/virology ; Cyclin-Dependent Kinases/antagonists & inhibitors ; Cyclin-Dependent Kinases/metabolism ; Drug Evaluation, Preclinical/methods ; HEK293 Cells ; Host-Pathogen Interactions ; Humans ; Pandemics ; Peptidyl-Dipeptidase A/genetics ; Peptidyl-Dipeptidase A/metabolism ; Phosphatidylinositol 3-Kinases/metabolism ; Phosphoinositide-3 Kinase Inhibitors/pharmacology ; Phosphorylation ; Pneumonia, Viral/metabolism ; Pneumonia, Viral/virology ; Protein Kinase Inhibitors/pharmacology ; Proteomics/methods ; Proto-Oncogene Proteins/antagonists & inhibitors ; Proto-Oncogene Proteins/metabolism ; Receptor Protein-Tyrosine Kinases/antagonists & inhibitors ; Receptor Protein-Tyrosine Kinases/metabolism ; SARS-CoV-2 ; Spike Glycoprotein, Coronavirus/metabolism ; Vero Cells ; p38 Mitogen-Activated Protein Kinases/antagonists & inhibitors ; p38 Mitogen-Activated Protein Kinases/metabolism ; Axl Receptor Tyrosine Kinase
    Chemical Substances Antiviral Agents ; Phosphoinositide-3 Kinase Inhibitors ; Protein Kinase Inhibitors ; Proto-Oncogene Proteins ; Spike Glycoprotein, Coronavirus ; spike protein, SARS-CoV-2 ; PIKFYVE protein, human (EC 2.7.1.137) ; Receptor Protein-Tyrosine Kinases (EC 2.7.10.1) ; Casein Kinase II (EC 2.7.11.1) ; Cyclin-Dependent Kinases (EC 2.7.11.22) ; p38 Mitogen-Activated Protein Kinases (EC 2.7.11.24) ; Peptidyl-Dipeptidase A (EC 3.4.15.1) ; ACE2 protein, human (EC 3.4.17.23) ; Angiotensin-Converting Enzyme 2 (EC 3.4.17.23) ; Axl Receptor Tyrosine Kinase
    Keywords covid19
    Language English
    Publishing date 2020-06-28
    Publishing country United States
    Document type Journal Article ; Research Support, N.I.H., Extramural ; Research Support, Non-U.S. Gov't ; Research Support, U.S. Gov't, Non-P.H.S.
    ZDB-ID 187009-9
    ISSN 1097-4172 ; 0092-8674
    ISSN (online) 1097-4172
    ISSN 0092-8674
    DOI 10.1016/j.cell.2020.06.034
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article ; Online: A SARS-CoV-2 protein interaction map reveals targets for drug repurposing.

    Gordon, David E / Jang, Gwendolyn M / Bouhaddou, Mehdi / Xu, Jiewei / Obernier, Kirsten / White, Kris M / O'Meara, Matthew J / Rezelj, Veronica V / Guo, Jeffrey Z / Swaney, Danielle L / Tummino, Tia A / Hüttenhain, Ruth / Kaake, Robyn M / Richards, Alicia L / Tutuncuoglu, Beril / Foussard, Helene / Batra, Jyoti / Haas, Kelsey / Modak, Maya /
    Kim, Minkyu / Haas, Paige / Polacco, Benjamin J / Braberg, Hannes / Fabius, Jacqueline M / Eckhardt, Manon / Soucheray, Margaret / Bennett, Melanie J / Cakir, Merve / McGregor, Michael J / Li, Qiongyu / Meyer, Bjoern / Roesch, Ferdinand / Vallet, Thomas / Mac Kain, Alice / Miorin, Lisa / Moreno, Elena / Naing, Zun Zar Chi / Zhou, Yuan / Peng, Shiming / Shi, Ying / Zhang, Ziyang / Shen, Wenqi / Kirby, Ilsa T / Melnyk, James E / Chorba, John S / Lou, Kevin / Dai, Shizhong A / Barrio-Hernandez, Inigo / Memon, Danish / Hernandez-Armenta, Claudia / Lyu, Jiankun / Mathy, Christopher J P / Perica, Tina / Pilla, Kala Bharath / Ganesan, Sai J / Saltzberg, Daniel J / Rakesh, Ramachandran / Liu, Xi / Rosenthal, Sara B / Calviello, Lorenzo / Venkataramanan, Srivats / Liboy-Lugo, Jose / Lin, Yizhu / Huang, Xi-Ping / Liu, YongFeng / Wankowicz, Stephanie A / Bohn, Markus / Safari, Maliheh / Ugur, Fatima S / Koh, Cassandra / Savar, Nastaran Sadat / Tran, Quang Dinh / Shengjuler, Djoshkun / Fletcher, Sabrina J / O'Neal, Michael C / Cai, Yiming / Chang, Jason C J / Broadhurst, David J / Klippsten, Saker / Sharp, Phillip P / Wenzell, Nicole A / Kuzuoglu-Ozturk, Duygu / Wang, Hao-Yuan / Trenker, Raphael / Young, Janet M / Cavero, Devin A / Hiatt, Joseph / Roth, Theodore L / Rathore, Ujjwal / Subramanian, Advait / Noack, Julia / Hubert, Mathieu / Stroud, Robert M / Frankel, Alan D / Rosenberg, Oren S / Verba, Kliment A / Agard, David A / Ott, Melanie / Emerman, Michael / Jura, Natalia / von Zastrow, Mark / Verdin, Eric / Ashworth, Alan / Schwartz, Olivier / d'Enfert, Christophe / Mukherjee, Shaeri / Jacobson, Matt / Malik, Harmit S / Fujimori, Danica G / Ideker, Trey / Craik, Charles S / Floor, Stephen N / Fraser, James S / Gross, John D / Sali, Andrej / Roth, Bryan L / Ruggero, Davide / Taunton, Jack / Kortemme, Tanja / Beltrao, Pedro / Vignuzzi, Marco / García-Sastre, Adolfo / Shokat, Kevan M / Shoichet, Brian K / Krogan, Nevan J

    Nature

    2020  Volume 583, Issue 7816, Page(s) 459–468

    Abstract: A newly described coronavirus named severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which is the causative agent of coronavirus disease 2019 (COVID-19), has infected over 2.3 million people, led to the death of more than 160,000 individuals ...

    Abstract A newly described coronavirus named severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which is the causative agent of coronavirus disease 2019 (COVID-19), has infected over 2.3 million people, led to the death of more than 160,000 individuals and caused worldwide social and economic disruption
    MeSH term(s) Animals ; Antiviral Agents/classification ; Antiviral Agents/pharmacology ; Betacoronavirus/drug effects ; Betacoronavirus/genetics ; Betacoronavirus/metabolism ; Betacoronavirus/pathogenicity ; COVID-19 ; Chlorocebus aethiops ; Cloning, Molecular ; Coronavirus Infections/drug therapy ; Coronavirus Infections/immunology ; Coronavirus Infections/metabolism ; Coronavirus Infections/virology ; Drug Evaluation, Preclinical ; Drug Repositioning ; HEK293 Cells ; Host-Pathogen Interactions/drug effects ; Humans ; Immunity, Innate ; Mass Spectrometry ; Molecular Targeted Therapy ; Pandemics ; Pneumonia, Viral/drug therapy ; Pneumonia, Viral/immunology ; Pneumonia, Viral/metabolism ; Pneumonia, Viral/virology ; Protein Binding ; Protein Biosynthesis/drug effects ; Protein Domains ; Protein Interaction Mapping ; Protein Interaction Maps ; Receptors, sigma/metabolism ; SARS-CoV-2 ; SKP Cullin F-Box Protein Ligases/metabolism ; Vero Cells ; Viral Proteins/genetics ; Viral Proteins/metabolism ; COVID-19 Drug Treatment
    Chemical Substances Antiviral Agents ; Receptors, sigma ; Viral Proteins ; SKP Cullin F-Box Protein Ligases (EC 2.3.2.27)
    Keywords covid19
    Language English
    Publishing date 2020-04-30
    Publishing country England
    Document type Journal Article ; Research Support, N.I.H., Extramural ; Research Support, Non-U.S. Gov't ; Research Support, U.S. Gov't, Non-P.H.S.
    ZDB-ID 120714-3
    ISSN 1476-4687 ; 0028-0836
    ISSN (online) 1476-4687
    ISSN 0028-0836
    DOI 10.1038/s41586-020-2286-9
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article ; Online: A SARS-CoV-2-Human Protein-Protein Interaction Map Reveals Drug Targets and Potential Drug-Repurposing

    Gordon, David E. / Jang, Gwendolyn M. / Bouhaddou, Mehdi / Xu, Jiewei / Obernier, Kirsten / O'Meara, Matthew J / Guo, Jeffrey Z. / Swaney, Danielle L. / Tummino, Tia A. / Huttenhain, Ruth / Kaake, Robyn M. / Richards, Alicia L. / Tutuncuoglu, Beril / Foussard, Helene / Batra, Jyoti / Haas, Kelsey / Modak, Maya / Kim, Minkyu / Haas, Paige /
    Polacco, Benjamin J. / Braberg, Hannes / Fabius, Jacqueline M. / Eckhardt, Manon / Soucheray, Margaret / Bennett, Melanie J. / Cakir, Merve / McGregor, Michael J. / Li, Qiongyu / Naing, Zun Zar Chi / Zhou, Yuan / Peng, Shiming / Kirby, Ilsa T. / Melnyk, James E. / Chorba, John S / Lou, Kevin / Dai, Shizhong A. / Shen, Wenqi / Shi, Ying / Zhang, Ziyang / Barrio-Hernandez, Inigo / Memon, Danish / Hernandez-Armenta, Claudia / Mathy, Christopher J.P. / Perica, Tina / Pilla, Kala B. / Ganesan, Sai J. / Saltzberg, Daniel J. / Ramachandran, Rakesh / Liu, Xi / Rosenthal, Sara B. / Calviello, Lorenzo / Venkataramanan, Srivats / Liboy-Lugo, Jose / Lin, Yizhu / Wankowicz, Stephanie A. / Bohn, Markus / Sharp, Phillip P. / Trenker, Raphael / Young, Janet M. / Cavero, Devin A. / Hiatt, Joseph / Roth, Theo / Rathore, Ujjwal / Subramanian, Advait / Noack, Julia / Hubert, Mathieu / Roesch, Ferdinand / Vallet, Thomas / Meyer, Björn / White, Kris M. / Miorin, Lisa / Rosenberg, Oren S. / Verba, Kliment A. / Agard, David / Ott, Melanie / Emerman, Michael / Ruggero, Davide / Garcí-Sastre, Adolfo / Jura, Natalia / von Zastrow, Mark / Taunton, Jack / Ashworth, Alan / Schwartz, Olivier / Vignuzzi, Marco / d'Enfert, Christophe / Mukherjee, Shaeri / Jacobson, Matt / Malik, Harmit S. / Fujimori, Danica G / Ideker, Trey / Craik, Charles S / Floor, Stephen / Fraser, James S. / Gross, John / Sali, Andrej / Kortemme, Tanja / Beltrao, Pedro / Shokat, Kevan / Shoichet, Brian K. / Krogan, Nevan J.

    bioRxiv

    Abstract: An outbreak of the novel coronavirus SARS-CoV-2, the causative agent of COVID-19 respiratory disease, has infected over 290,000 people since the end of 2019, killed over 12,000, and caused worldwide social and economic disruption. There are currently no ... ...

    Abstract An outbreak of the novel coronavirus SARS-CoV-2, the causative agent of COVID-19 respiratory disease, has infected over 290,000 people since the end of 2019, killed over 12,000, and caused worldwide social and economic disruption. There are currently no antiviral drugs with proven efficacy nor are there vaccines for its prevention. Unfortunately, the scientific community has little knowledge of the molecular details of SARS-CoV-2 infection. To illuminate this, we cloned, tagged and expressed 26 of the 29 viral proteins in human cells and identified the human proteins physically associated with each using affinity-purification mass spectrometry (AP-MS), which identified 332 high confidence SARS-CoV-2-human protein-protein interactions (PPIs). Among these, we identify 67 druggable human proteins or host factors targeted by 69 existing FDA-approved drugs, drugs in clinical trials and/or preclinical compounds, that we are currently evaluating for efficacy in live SARS-CoV-2 infection assays. The identification of host dependency factors mediating virus infection may provide key insights into effective molecular targets for developing broadly acting antiviral therapeutics against SARS-CoV-2 and other deadly coronavirus strains.
    Keywords covid19
    Language English
    Publishing date 2020-03-27
    Publisher Cold Spring Harbor Laboratory
    Document type Article ; Online
    DOI 10.1101/2020.03.22.002386
    Database COVID19

    Kategorien

To top